Meta Analysis of HuangQi Injection in Treating Cerebral Infarction

Xiaohuai WANG,Jianing KOU,Wen PAN,Shuying LIU

DOI: https://doi.org/10.3969/j.issn.1004-6852.2014.10.025

2014-01-01

Abstract:Objective: To evaluate curative effects and the safety of HuangQi injection in treating cerebral infarction. Methods:MEDLINE, EMbase, Cochrane Library, CNKI, VIP and WanFang database were searched by the computer, the information was screened and extracted independently by two researchers according to the including and excluding criteria. The quality of the included studies was evaluated based on quality assessment standard of the randomized controlled trials in Cochrane Library, Meta analysis was performed by Rev Man 5.2 software. Results:Ten articles were included, involving 864 patients. There was no death reported in ten pieces of the articles, and mortality rate was 0%. The results of Meta analysis showed:clinical efficacy [RR=1.21,95%CI(1.13, 1.29)] and the improvement of neurological impairment [MD=-3.28, 95%CI (-5.27,-1.29)] of HuangQi injection group were superior to these of the control group, the difference had statistical meaning. Among ten articles, there was no obvious adverse reaction reported in four articles, the safety and adverse reaction were not mentioned in three articles, there were adverse reaction reported in two articles but without the detailed grouping, only one article described two cases with slight diarrhea and one case with local itching in the experiment group. Conclusion:HuangQi injection in treating cerebral infarction might be superior to the drugs of the control group in improving clinical effects and neurological impairment scales, because of low quality of the included study with small sample size and unclear drug safety, it still needs to be further tested by high quality randomized controlled trials.